Friday, December 23, 2016 Written by Jared Tipton, Senior Director of Corporate Communications, Cepheid

Next Generation Molecular Diagnostics: Application of the GeneXpert® Platform to Oncology

Next Generation Molecular Diagnostics: Application of the GeneXpert® Platform to Oncology

Real-World Workshop Series Webinar - December 2012

Presenter: Dr. Michael Bates

Dr. Mike Bates discusses Cepheid’s activities in the Oncology testing arena: bringing the GeneXpert System's familiar simplicity and fully integrated testing to oncology.

He also describes oncology testing strategies in our Lung, Colon, Prostate, Breast, and Hematological cancer testing programs. How would it impact your institution to have rapid, accurate oncology tests of moderate complexity?

LISTEN TO THE ARCHIVED WEBINAR

Published in Impact Workshop Series
Download attachments:
More in this Issue « Clostridium difficile: Improvements in Patient Management Use of Standalone Rapid Molecular Test in Acute Hospital Setting Antimicrobial Stewardship in the Emergency Department: Opportunities and Challenges for Rapid Diagnostics »
back to top